Avecho Biotechnology Ord Shs V.AVE

Primary Symbol: AVEFF

Healthcare

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

OTCPK:AVEFF - Post by User

Avecho Biotechnology Ord Shs > Aveda shareholders Cash Contingent Consideration

<< Previous

Bullboard Posts

Next >>

Comment by rusty777on Mar 31, 2019 3:20pm

57 Views

Post# 29561088

RE:RE:RE:Aveda shareholders Cash Contingent Consideration

Thanks for the info Johnny

I agree, I would certainly have done things differently in hindsight.....however, a year ago who would have thought that they would have increased revenue by over 100% while at the same time reducing earnings by 120%?

It's really pathetic when you think about it.....neither you, nor I, would get away with such a performance let alone get a performance bonus. They really must think all of us mere shareholders are dumb as stumps.

Ah well,....live and learn

Sadly

Rusty

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023